1	Identification	identification	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	human	human	_	_	_	_	_	_	_
5	LIM-Hox	LIM-Hox	_	_	_	_	_	_	_
6	gene	gene	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	hLH-2	hlh-2	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	aberrantly	aberrantly	_	_	_	_	_	_	_
11	expressed	express	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	chronic	chronic	_	_	_	_	_	_	_
14	myelogenous	myelogenous	_	_	_	_	_	_	_
15	leukaemia	leukaemia	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	located	locate	_	_	_	_	_	_	_
18	on	on	_	_	_	_	_	_	_
19	9q33-34.1	9q33-34.1	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	describe	describe	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	isolation	isolation	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	human	human	_	_	_	_	_	_	_
7	LH-2	lh-2	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	a	a	_	_	_	_	_	_	_
10	putative	putative	_	_	_	_	_	_	_
11	transcription	transcription	_	_	_	_	_	_	_
12	factor	factor	_	_	_	_	_	_	_
13	containing	contain	_	_	_	_	_	_	_
14	two	two	_	_	_	_	_	_	_
15	cysteine-rich	cysteine-rich	_	_	_	_	_	_	_
16	regions	region	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	LIM	LIM	_	_	_	_	_	_	_
19	domains	domain	_	_	_	_	_	_	_
20	)	)	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	a	a	_	_	_	_	_	_	_
23	homeobox	homeobox	_	_	_	_	_	_	_
24	(	(	_	_	_	_	_	_	_
25	Hox	Hox	_	_	_	_	_	_	_
26	)	)	_	_	_	_	_	_	_
27	DNA-binding	dna-binding	_	_	_	_	_	_	_
28	domain	domain	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	High	high	_	_	_	_	_	_	_
2	levels	level	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	hLH-2	hlh-2	_	_	_	_	_	_	_
5	expression	expression	_	_	_	_	_	_	_
6	were	be	_	_	_	_	_	_	_
7	observed	observe	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	all	all	_	_	_	_	_	_	_
10	cases	case	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	chronic	chronic	_	_	_	_	_	_	_
13	myelogenous	myelogenous	_	_	_	_	_	_	_
14	leukaemia	leukaemia	_	_	_	_	_	_	_
15	(	(	_	_	_	_	_	_	_
16	CML	CML	_	_	_	_	_	_	_
17	)	)	_	_	_	_	_	_	_
18	tested	test	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	regardless	regardless	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	disease	disease	_	_	_	_	_	_	_
23	status.	status.	_	_	_	_	_	_	_
24	hLH-2	hlh-2	_	_	_	_	_	_	_
25	was	be	_	_	_	_	_	_	_
26	mapped	map	_	_	_	_	_	_	_
27	to	to	_	_	_	_	_	_	_
28	chromosome	chromosome	_	_	_	_	_	_	_
29	9Q33-34.1	9q33-34.1	_	_	_	_	_	_	_
30	,	,	_	_	_	_	_	_	_
31	in	in	_	_	_	_	_	_	_
32	the	the	_	_	_	_	_	_	_
33	same	same	_	_	_	_	_	_	_
34	region	region	_	_	_	_	_	_	_
35	as	as	_	_	_	_	_	_	_
36	the	the	_	_	_	_	_	_	_
37	reciprocal	reciprocal	_	_	_	_	_	_	_
38	translocation	translocation	_	_	_	_	_	_	_
39	that	that	_	_	_	_	_	_	_
40	creates	create	_	_	_	_	_	_	_
41	the	the	_	_	_	_	_	_	_
42	BCR-ABL	bcr-abl	_	_	_	_	_	_	_
43	chimera	chimera	_	_	_	_	_	_	_
44	of	of	_	_	_	_	_	_	_
45	the	the	_	_	_	_	_	_	_
46	Philadelphia	Philadelphia	_	_	_	_	_	_	_
47	chromosome	chromosome	_	_	_	_	_	_	_
48	(	(	_	_	_	_	_	_	_
49	Ph	Ph	_	_	_	_	_	_	_
50	â€™	'	_	_	_	_	_	_	_
51	)	)	_	_	_	_	_	_	_
52	,	,	_	_	_	_	_	_	_
53	the	the	_	_	_	_	_	_	_
54	hallmark	hallmark	_	_	_	_	_	_	_
55	of	of	_	_	_	_	_	_	_
56	CML	CML	_	_	_	_	_	_	_
57	;	;	_	_	_	_	_	_	_
58	hLH-2	hlh-2	_	_	_	_	_	_	_
59	was	be	_	_	_	_	_	_	_
60	retained	retain	_	_	_	_	_	_	_
61	on	on	_	_	_	_	_	_	_
62	the	the	_	_	_	_	_	_	_
63	derivative	derivative	_	_	_	_	_	_	_
64	9	9	_	_	_	_	_	_	_
65	chromosome	chromosome	_	_	_	_	_	_	_
66	and	and	_	_	_	_	_	_	_
67	is	be	_	_	_	_	_	_	_
68	therefore	therefore	_	_	_	_	_	_	_
69	centromeric	centromeric	_	_	_	_	_	_	_
70	of	of	_	_	_	_	_	_	_
71	c-ABL	c-abl	_	_	_	_	_	_	_
72	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	proximity	proximity	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	hLH-2	hlh-2	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	breakpoint	breakpoint	_	_	_	_	_	_	_
8	on	on	_	_	_	_	_	_	_
9	chromosome	chromosome	_	_	_	_	_	_	_
10	9	9	_	_	_	_	_	_	_
11	raises	raise	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	possibility	possibility	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	cis-activation	cis-activation	_	_	_	_	_	_	_
16	by	by	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	t(9;22)(q34;q11)	t(9;22)(q34;q11)	_	_	_	_	_	_	_
19	translocation	translocation	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	to	to	_	_	_	_	_	_	_
4	finding	find	_	_	_	_	_	_	_
5	hLH-2	hlh-2	_	_	_	_	_	_	_
6	expression	expression	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	all	all	_	_	_	_	_	_	_
9	cases	case	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	CML	CML	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	expression	expression	_	_	_	_	_	_	_
14	was	be	_	_	_	_	_	_	_
15	observed	observe	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	lymphoid	lymphoid	_	_	_	_	_	_	_
18	malignancies	malignancy	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	myeloid	myeloid	_	_	_	_	_	_	_
21	cell	cell	_	_	_	_	_	_	_
22	lines	line	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	but	but	_	_	_	_	_	_	_
25	not	not	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	primary	primary	_	_	_	_	_	_	_
28	cases	case	_	_	_	_	_	_	_
29	of	of	_	_	_	_	_	_	_
30	acute	acute	_	_	_	_	_	_	_
31	myelogenous	myelogenous	_	_	_	_	_	_	_
32	leukaemia	leukaemia	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	role	role	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	hLH-2	hlh-2	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	development	development	_	_	_	_	_	_	_
8	or	or	_	_	_	_	_	_	_
9	progression	progression	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	leukaemia	leukaemia	_	_	_	_	_	_	_
12	is	be	_	_	_	_	_	_	_
13	not	not	_	_	_	_	_	_	_
14	known	know	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	hLH-2	hlh-2	_	_	_	_	_	_	_
4	may	may	_	_	_	_	_	_	_
5	prove	prove	_	_	_	_	_	_	_
6	useful	useful	_	_	_	_	_	_	_
7	as	as	_	_	_	_	_	_	_
8	a	a	_	_	_	_	_	_	_
9	marker	marker	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	CML	CML	_	_	_	_	_	_	_
12	for	for	_	_	_	_	_	_	_
13	monitoring	monitor	_	_	_	_	_	_	_
14	residual	residual	_	_	_	_	_	_	_
15	disease	disease	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

